Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes. | Clin Exp Immunol;164(1): 26-41, 2011 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.

Tohn, R; Blumenfeld, H; Haeryfar, S M M; Veerapen, N; Besra, G S; Porcelli, S A; Delovitch, T L.

Affiliation

Tohn R; Laboratory of Autoimmune Diabetes, Robarts Research Institute Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.

Clin Exp Immunol ; 164(1): 26-41, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21361909

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clonal Anergy / Diabetes Mellitus, Type 1 / Natural Killer T-Cells / Galactosylceramides Language: En Journal: Clin Exp Immunol Year: 2011 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clonal Anergy / Diabetes Mellitus, Type 1 / Natural Killer T-Cells / Galactosylceramides Language: En Journal: Clin Exp Immunol Year: 2011 Document type: Article Affiliation country: